1416 Results

People

  1. Motzer
    Motzer
  2. Vickers
    Vickers
  3. Hudis
    Hudis
  4. Norton
    Norton
  5. Saltz
    Saltz
  6. O'Reilly
    O'Reilly
  7. Mao
    Mao
  8. Morris
    Morris
  9. Seidman
    Seidman
  10. Kris
    Kris

Groups

  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)
  7. Hematologic Malignancies, Division of (169)
  8. Genitourinary Oncology Service (160)
  9. Center for Hematologic Malignancies (142)
  10. Gastrointestinal Oncology Service (126)
  1. "randomized controlled trial"
Formats
  1. Journal Article (1353)
  2. Review (19)
  3. Conference Paper (17)
  4. Editorial (9)
  5. Correspondence (5)
  6. Research Letter (5)
  7. Meeting Abstract (4)
  8. Guidelines (3)
  9. Book Section (1)
Groups
  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)

More Groups

People
  1. Robert Motzer (83)
  2. Andrew Vickers (48)
  3. Larry Norton (34)
  4. Clifford Hudis (33)
  5. Leonard Saltz (32)
  6. Eileen O'Reilly (25)

More People

Years
  1. 2025 (63)
  2. 2024 (165)
  3. 2023 (110)
  4. 2022 (81)
  5. 2021 (39)
  6. 2020 (51)

More Years

Publications
  1. Journal of Clinical Oncology (164)
  2. New England Journal of Medicine (65)
  3. Lancet Oncology (46)
  4. Cancer (42)
  5. Clinical Cancer Research (42)
  6. European Urology (26)

More Publications

Publishers
  1. Elsevier Inc. (187)
  2. American Society of Clinical Oncology (170)
  3. Elsevier Science, Inc. (138)
  4. Springer (79)
  5. Lippincott Williams & Wilkins (72)
  6. Wiley Blackwell (71)

More Publishers

Results (1416)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Young age on starting prostate-specific antigen testing is associated with a greater reduction in prostate cancer mortality: 24-year follow-up of the Göteborg randomized population-based prostate cancer screening trial
    Journal Article

    Carlsson, S. V.; Arnsrud Godtman, R.; Pihl, C. G.; Vickers, A.; Lilja, H.; Hugosson, J.; Månsson, M.
    European Urology (2023)

    Fulltext@MSK | Save
  • Mechanistic and thermal characterization of acupuncture for chemotherapy-induced peripheral neuropathy as measured by quantitative sensory testing
    Journal Article

    Zhi, W. I.; Baser, R. E.; Talukder, D.; Mei, Y. Z.; Harte, S. E.; Bao, T.
    Breast Cancer Research and Treatment (2023)

    Fulltext@MSK | Save
  • Discussion: Breast reconstruction decision aids decrease decisional conflict and improve decisional satisfaction: A randomized controlled trial
    Correspondence

    Sheckter, C. C.; Matros, E.
    Plastic and Reconstructive Surgery (2023)

    Fulltext@MSK | Save
  • Lobar or sublobar resection for peripheral stage IA non-small-cell lung cancer
    Journal Article

    Altorki, N.; Wang, X.; Kozono, D.; Watt, C.; Landrenau, R.; Wigle, D.; Port, J.; Jones, D. R.; Conti, M.; Ashrafi, A. S.; more...
    New England Journal of Medicine (2023)

    Fulltext@MSK | Save
  • Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): A randomised, double-blind, placebo-controlled, multicentre, phase 2 trial
    Journal Article

    Sherman, E. J.; Harris, J.; Bible, K. C.; Xia, P.; Ghossein, R. A.; Chung, C. H.; Riaz, N.; Gunn, G. B.; Foote, R. L.; Yom, S. S.; more...
    Lancet Oncology (2023)

    Fulltext@MSK | Save
  • Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS): Interim analysis of a randomised, open-label, phase 3 trial
    Journal Article

    Dytfeld, D.; Wróbel, T.; Jamroziak, K.; Kubicki, T.; Robak, P.; Walter-Croneck, A.; Czyż, J.; Tyczyńska, A.; Druzd-Sitek, A.; Giannopoulos, K.; more...
    Lancet Oncology (2023)

    Fulltext@MSK | Save
  • Five-year survival outcomes with nivolumab plus ipilimumab versus chemotherapy as first-line treatment for metastatic non-small-cell lung cancer in CheckMate 227
    Journal Article

    Brahmer, J. R.; Lee, J. S.; Ciuleanu, T. E.; Bernabe Caro, R.; Nishio, M.; Urban, L.; Audigier-Valette, C.; Lupinacci, L.; Sangha, R.; Pluzanski, A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Effect of oral β-glucan on antibody response to ganglioside vaccine in patients with high-risk neuroblastoma: A phase 2 randomized clinical trial
    Journal Article

    Cheung, I. Y.; Mauguen, A.; Modak, S.; Ragupathi, G.; Basu, E. M.; Roberts, S. S.; Kushner, B. H.; Cheung, N. K.
    JAMA Oncology (2023)

    Fulltext@MSK | Save
  • Impact of baseline expectancy on outcome prediction of real and sham acupuncture for persistent chemotherapy-induced peripheral neuropathy pain in solid tumor survivors: A secondary analysis of a randomized clinical trial
    Journal Article

    Li, X.; Zhi, L.; Han, K. Y.; Li, S. Q.; Ahmad, K.; Seluzicki, C.; Wang, R.; Bao, T.
    Integrative Cancer Therapies (2023)

    Fulltext@MSK | Save
  • Radiologic and histopathologic features of hydrogel sealant after lung resection in participants of a prospective randomized clinical trial
    Journal Article

    Moussa, A. M.; Hui, Y.; Araujo Filho, J. A.; Muallem, N.; Li, D.; Jihad, M.; Hsu, M.; Moskowitz, C. S.; Travis, W. D.; Solomon, S. B.; more...
    Clinical Imaging (2023)

    Fulltext@MSK | Save